
When Boards Undermine CEOs: How ‘Help' Turns Into Harm
Board Engagement Goes Into Overdrive
Instead of giving management space to course correct, boards increase the volume of requests and deepen their involvement. Management ends up spending more time preparing decks or responding to board questions than solving problems and addressing issues.
You're Pushed To Engage Board-Favored Firms Or Consultants
Even well-intentioned referrals can feel politically loaded if those advisors are seen as board proxies rather than true partners to the CEO and management team.
The Chair Dominates; Other Board Members Stay Quiet
Power can become concentrated in a single board member, especially in crisis or founder-led environments. Without active participation or leadership from the rest of the board, governance suffers, and CEOs are left navigating a one-person approval funnel.
Founders Who Sit On Boards Interfere
In founder-led or founder-influenced companies, legacy leaders may continue to attend internal meetings or offer informal input. While their insight can be valuable, this often confuses authority and undermines the CEO's role in leading.
The Appetite For Detail Becomes Unmanageable
Some diligence is essential. But when board members dive too deep or question every metric or data point, it doesn't just slow things down — it sends an implicit message: 'I don't trust you.'
Why It's Happening More Often
The broader environment is contributing: Tariffs, supply chain volatility, geopolitical instability — these headwinds increase pressure on boards to 'do something.' When numbers dip, so does confidence, and without visible progress, some boards stop believing the leadership team has it under control and start stepping in. This dynamic can be even more pronounced in founder-led, PE-backed, or highly operational boards, where the distinction between governing and managing may not be as clearly defined.
Another sensitivity: Many management teams see the breakdown coming before the CEO does. They may want the CEO to push back on the board, but that's no small task. Boards hold power, and speaking up takes political capital and comes with real risk.
How To Reset Your Relationship With The Board: First Steps
While overreach from the board can become frustrating, exhausting, and disappointing for management teams, the dynamic presents an opportunity to reestablish boundaries, grow trust, and strengthen transparency. Consider these steps:
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
an hour ago
- Business Upturn
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
By GlobeNewswire Published on August 5, 2025, 03:45 IST WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) ('iSpecimen' or the 'Company'), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to pay $500,000 for marketing and advertising services to be provided by IR Agency LLC, and the remainder for working capital and general corporate purposes. In connection with the offering, the Company issued 1,559,828 shares of common stock (or pre-funded warrants to purchase shares of common stock) at a purchase price of $1.122 per share, priced at-the-market under Nasdaq rules. The offering closed on August 4, 2025. WestPark Capital, Inc. acted as the exclusive placement agent in connection with the offering. Additional details regarding the offering will be available in a Form 8-K to be filed by the Company with the Securities and Exchange Commission (the 'SEC'). The securities described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About iSpecimen iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit . Safe Harbor Statement Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The reader is cautioned not to rely on such forward-looking statements. Such forward-looking statements relate to future events or our future performance. In evaluating these forward-looking statements, you should consider various factors, including the uncertainty regarding future commercial success; risks and uncertainties associated with market conditions and the Company's ability to satisfy the closing conditions related to the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions and actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 14, 2025, as well as other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, iSpecimen specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.


Business Upturn
an hour ago
- Business Upturn
HCM III Acquisition Corp Announces Closing of $253,000,000 Initial Public Offering
STAMFORD, Ct, Aug. 04, 2025 (GLOBE NEWSWIRE) — HCM III Acquisition Corp (Nasdaq: HCMAU) (the 'Company'), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today the closing of its previously announced initial public offering of 25,300,000 units, including 3,300,000 units issued pursuant to the full exercise by the underwriter of its over-allotment option. The units were sold at a price of $10.00 per unit. The Company's units began trading on August 1, 2025 on the Nasdaq Global Market under the symbol 'HCMAU'. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant is exercisable to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the Nasdaq Global Market under the ticker symbols 'HCMA' and 'HCMAW,' respectively. The Company intends to focus on identifying businesses which provide disruptive technology or innovations within the financial services industry. The Company's efforts will be focused on acquiring established businesses that it believes are fundamentally sound, but in need of assistance to maximize their potential value. The Company is led by Shawn Matthews, Chairman and Chief Executive Officer; and Steven Bischoff, President and Chief Financial Officer. Cantor Fitzgerald & Co. acted as sole bookrunner for the offering. A registration statement relating to the securities was filed with, and declared effective by, the Securities and Exchange Commission ('SEC') on July 31, 2025. The public offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from: Cantor Fitzgerald & Co., Attention Capital Markets, 499 Park Avenue, New York, NY 10022, or by e-mail at [email protected]. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About HCM III Acquisition Corp HCM III Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on identifying businesses which provide disruptive technology or innovations within the financial services industry. The Company's efforts will be focused on acquiring established businesses that it believes are fundamentally sound, but in need of assistance to maximize their potential value. FORWARD-LOOKING STATEMENTS This press release contains statements that constitute 'forward-looking statements.' Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the 'Risk Factors' section of the Company's registration statement filed with the SEC and the preliminary prospectus included therein. Copies of these documents are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Media Contact: Steven Bischoff [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


E&E News
an hour ago
- E&E News
Court OKs Trump plan to curtail unions at EPA, Interior, DOE
A federal appeals court cleared the way last week for the Trump administration to pursue plans to end collective bargaining for employees at the Interior and Energy departments, EPA and other agencies, even as unions are challenging the changes in court. On Friday, the 9th U.S. Circuit Court of Appeals paused a lower court order that prevented the administration from enforcing President Donald Trump's March executive order barring collective bargaining at more than two dozen agencies and sub-agencies based on national security concerns. The new order, an emergency stay, is in effect while the challenges to the EO works its way through the courts. Advertisement 'Whatever harm to collective bargaining rights that Plaintiffs will experience due to a stay is mitigated by the direction to agencies to refrain from terminating collective bargaining agreements until litigation has concluded,' the court said in an unsigned order.